
Sign up to save your podcasts
Or


The palm is ~0.5% TBSA -
Insurance companies denying coverage -
Malignancy risk in JAK inhibitors -
MACE risk in JAK inhibitors -
Oral azoles for head-and-neck dermatitis -
Luke's PDPC course and the Intermountain Derm Society meeting: https://registration.socio.events/e/idspdpc23/promo-codes/ATTENDEE
Connect with us!
- Web: https://dermaspherepodcast.com/
- Twitter: @DermaspherePC
- Instagram: dermaspherepodcast
- Facebook: https://www.facebook.com/DermaspherePodcast/
- Check out Luke and Michelle’s other podcast, SkinCast! https://healthcare.utah.edu/dermatology/skincast/
Luke and Michelle report no significant conflicts of interest… BUT check out our friends at:
- Kikoxp.com(a social platform for doctors to share knowledge)
- https://www.levelex.com/games/top-derm (A free dermatology game to learn more dermatology!)
By Luke Johnson4.9
132132 ratings
The palm is ~0.5% TBSA -
Insurance companies denying coverage -
Malignancy risk in JAK inhibitors -
MACE risk in JAK inhibitors -
Oral azoles for head-and-neck dermatitis -
Luke's PDPC course and the Intermountain Derm Society meeting: https://registration.socio.events/e/idspdpc23/promo-codes/ATTENDEE
Connect with us!
- Web: https://dermaspherepodcast.com/
- Twitter: @DermaspherePC
- Instagram: dermaspherepodcast
- Facebook: https://www.facebook.com/DermaspherePodcast/
- Check out Luke and Michelle’s other podcast, SkinCast! https://healthcare.utah.edu/dermatology/skincast/
Luke and Michelle report no significant conflicts of interest… BUT check out our friends at:
- Kikoxp.com(a social platform for doctors to share knowledge)
- https://www.levelex.com/games/top-derm (A free dermatology game to learn more dermatology!)

498 Listeners

291 Listeners

16 Listeners

1,154 Listeners

733 Listeners

14 Listeners

35 Listeners

382 Listeners

281 Listeners

100 Listeners

52 Listeners

4,511 Listeners

6 Listeners

3 Listeners

33 Listeners